Cellectis
(NASDAQ) CLLS
Cellectis Financials at a Glance
Market Cap
$308.83M
Revenue (TTM)
$72.95M
Net Income (TTM)
$67.57M
EPS (TTM)
$-0.68
P/E Ratio
-6.31
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$4.40
Volume
810
Open
$4.38
Price
$4.40
Volume
810
Open
$4.38
Previous Close
$4.40
Daily Range
$4.28 - $4.45
52-Week Range
$1.33 - $5.48
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$4.40
Volume
810
Open
$4.38
Previous Close
$4.40
Daily Range
$4.28 - $4.45
52-Week Range
$1.33 - $5.48
CLLS News
Is Cellectis SA Stock a Buy Now?
CLLS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cellectis
Industry
Biotechnology
Sector
Health CareEmployees
229
CEO
André Choulika, PhD
Website
www.cellectis.comHeadquarters
Paris, 75013, FR
CLLS Financials
Key Financial Metrics (TTM)
Gross Margin
84%
Operating Margin
-48%
Net Income Margin
-93%
Return on Equity
-66%
Return on Capital
-19%
Return on Assets
-21%
Earnings Yield
-15.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$308.83M
Shares Outstanding
72.33M
Volume
810
Short Interest
0.00%
Avg. Volume
44.32K
Financials (TTM)
Gross Profit
$53.05M
Operating Income
$40.48M
EBITDA
$20.36M
Operating Cash Flow
$40.14M
Capital Expenditure
$2.37M
Free Cash Flow
$42.50M
Cash & ST Invst.
$208.66M
Total Debt
$119.90M
Cellectis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.40M
-18.3%
Gross Profit
$2.70M
-126.5%
Gross Margin
-26.01%
N/A
Market Cap
$308.83M
N/A
Market Cap/Employee
$1.43M
N/A
Employees
216
N/A
Net Income
$26.30M
-544.1%
EBITDA
$19.61M
-238.3%
Quarterly Fundamentals
Net Cash
$88.76M
-47.4%
Accounts Receivable
$22.20M
-3.6%
Inventory
$0.00
N/A
Long Term Debt
$101.74M
+30.0%
Short Term Debt
$18.16M
+37.3%
Return on Assets
-20.89%
N/A
Return on Invested Capital
-19.41%
N/A
Free Cash Flow
$10.95M
-511.2%
Operating Cash Flow
$10.47M
-22183.9%